Botulinum neurotoxin A in ophthalmology

Ophthalmic and Physiological Optics

Volumn 16, Issue SUPPL. 1, 1996, Pages

  Bentley, Christopher ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

BLEPHAROSPASM; CORNEA DISEASE; ENTROPION; EYE DISEASE; FACIAL NERVE DISEASE; HUMAN; MYOKYMIA; NYSTAGMUS; PRIORITY JOURNAL; REVIEW; STRABISMUS;

EID: 0029939239     PISSN: 02755408     EISSN: None     Source Type: Journal    
DOI: 10.1016/0275-5408(95)00137-9     Document Type: Article

References (43)

1. Biglen, A. W., Burnstine, R. A., Rogers, G. L. and Saunders, R. A. (1989). Management of strabismus with botulinum A toxin. Ophthalmology 96, 935-943.
2. Brin, M. F. (1991). Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin. Arch. Neurobiol. 54 (Suppl 3), 7-23.
3. Carruthers, J. and Stubbs, H. A. (1987). Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age related lower eyelid entropion. Can. J. Neurol. Sci. 14, 42-45.
4. Clarke, J. R. and Spalton, D. J. (1988). Treatment of senile entropion with botulinum toxin. Br. J. Ophthalmol. 72, 361-362.
5. Cohen, D. A., Savino, P. J., Stern, M. B. and Hurtig, H. I. (1986). Botulinum injection therapy for blepharospasm: a review and report of 75 patients. Clin. Neuropharmocol. 9, 415-429.
6. DasGupta, B. R. (1994). Structure of botulinum neurotoxin, its functional domains, and perspectives on the crystalline type A toxin. In: Therapy with Botulinum Toxin (eds J. Jankovic and M. Hallett), Marcel Dekker, New York, USA, pp. 3-13.
7. Dreyer, F., Mallert, A. and Brigant, J. L. (1983). Botulinum A toxin and tetanus toxin do not affect presynaptic membrane currents in mammalian motor nerve endings. Brain Res. 270, 373-375.
8. Dutton, J. J. and Buckley, E. G. (1988). Long term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 95, 1529-1534.
9. Ellenhorn, M. J. and Barceloux, D. G. (1988). Medical Toxicology. Diagnosis and Treatment of Human Poisoning. Elsevier Science Ltd, New York, pp. 1185-1187.
10. Elston, J. S. (1987). Long term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Br. J. Ophthalmol. 71, 664-668.
11. Elston, J. S. and Russell, R. W. (1985). Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br. Med. J. 290, 1857-1859.
12. Frueh, B. R., Felt, D. P., Wojno, T. H. and Musch, D. C. (1984). Treatment of blepharospasm with botulinum toxin: a preliminary report. Arch. Ophthalmol. 102, 1464-1468.
13. Helveston, E. M. and Pogrebniak, A. E. (1988). Treatment of acquired nystagmus with botulinum A toxin. Am. J. Ophthalmol. 106, 585-586.
14. Jankovic, J. (1994). Botulinum toxin in movement disorders. Curr. Opinion Neurology 7, 358-366.
15. Jankovic, J. and Schwartz, K. S. (1993). Longitudinal follow up of botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 43, 834-836.
16. Kao, I., Drachman, D. B. and Price, D. L. (1976). Botulinum toxin: mechanism presynaptic blockade. Science 193, 1256-1258.
17. Kirkness, C. M., Adams, G. G., Dilly, P. N. and Lee, J. (1988). Botulinum toxin A induced protective ptosis in corneal disease. Ophthalmology 95, 473-480.
18. Lee, J. P. (1992). Modern management of sixth nerve palsy. Australian and New Zealand J. Ophthalmol. 20, 41-46.
19. Lee, J. P., Harris, S., Cohen, J., Cooper, K., MacEwan, C. and Jones, S. (1994). Results of a prospective randomized trial of botulinum toxin therapy in acute unilateral sixth nerve palsy. J. Ped. Ophthalmol. Strabismus 31, 283-286.
20. Magoon, E. H. (1986). Botulinum chemodenervation for strabismus and other disorders. Int. Ophthalmol. Clin. 25, 149-159.
21. Magoon, E. H. (1987). The use of botulinum toxin injection as an alternative to strabismus surgery. Contemp. Ophthalmic Forum 5, 222-229.
22. Malinovsky, V. (1987). Benign essential blepharospasm. J. Am. Optometric Assoc. 58, 646-651.
23. Mauriello, J. A., Coniaris, H. and Haupt, E. J. (1987). Use of botulinum toxin in the treatment of one hundred facial dyskinesias. Ophthalmology 94, 976-979.
24. McNeer, K. W., Spencer, R. F. and Tucker, M. G. (1994). Observations on bilateral simultaneous botulinum toxin injections in infantile esotropia, J. Ped. Ophthalmol. Strabismus 31, 214-219.
25. Metz, H. S. (1984). Botulinum injections for strabismus. J. Ped. Ophthalmol. Strabismus 21, 199-201.
26. Metz, H. S. and Dickey, C. (1991). Treatment of unilateral acute sixth nerve palsy with botulinum toxin. Am. J. Ophthalmol. 112, 381-384.
27. Metz, H. S. and Mazow, M. (1988). Botulinum toxin treatment of acute sixth and third nerve palsy. Graefe's Arch. Clin. Exp. Ophthalmol. 226, 141-144.
28. Mukuno, K., Scott, A. B. and Ishikawa, S. (1984). Histopathological study on the monkey extraocular muscles under botulinum toxin injection. In: Strabismus II: Proceedings of the Fourth Meeting of The International Strabismological Association (ed. R. D. Reinecke), Grune and Stratton, Orlando, USA, pp. 707-710.
29. Osako, M. and Keltner, J. L. (1991). Botulinum A toxin (oculinum) in ophthalmology. Surv. Ophthalmol. 36, 28-46.
30. Pearce, L. B., Borodic, G. E., First, E. R. and MacCallum, R. D. (1994). Measurement of botulinum toxin activity: evaluation of the lethality assay. Toxicol. Appl. Pharmacol. 128, 69-77.
31. Price, J. and O'Day, J. (1994). Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm. Australian and New Zealand J. Ophthalmol. 22 (4), 255-260.
32. Repka, M. X., Lam, G. C. and Morrison, N. A. (1994). The efficacy of botulinum neurotoxin A for the treatment of complete and partially recovered sixth nerve palsy. J. Ped. Ophthalmol. Strabismus 31, 79-83.
33. Riordan-Eva, P. and Lee, J. P. (1992). Management of VITH nerve palsy -avoiding unnecessary surgery. Eye 6, 386-390.
34. Schantz, E. J. and Scott, A. B. (1981). Use of crystalline type A botulinum toxin in medical research. In: Biomedical Aspects of Botulism (ed. G. E. Lewis), Academic Press, New York, USA, pp. 143-149.
35. Scott, A. B. (1981). Botulinum toxin injection of eye muscles to correct strabismus. Trans. Am. Ophthalmol. Soc. 79, 734-770.
36. Scott, A. B. (1989). Botulinum toxin treatment of strabismus. Focal points 1989: Clinical Modules for Ophthalmologists, San Francisco American Academy of Ophthalmology, Vol. 7, pp. 1-11.
37. Scott, A. B. (1990). Botulinum treatment of strabismus following retinal detachment surgery. Arch. Ophthalmol. 108, 509-510.
38. Scott, A. B. and Kraft, S. P. (1985). Botulinum toxin injection in the management of lateral rectus paresis. Ophthalmology, 92, 676-683.
39. Scott, A. B., Rosenbaum, A. and Collins, C. C. (1973). Pharmacologic weakening of extraocular muscles. Invest. Ophthalmol. 12 (12), 924-927.
40. Scott, A. B., Magoon, E. H., McNeer, K. W. and Stager, D. R. (1990). Botulinum treatment of childhood strabismus. Ophthalmology 97 (11), 1434-1438.
41. Simpson, L. L. (1981). The origin structure, and pharmacological activity of botulinum toxin. Pharmacol. Rev. 33, 155-188.
42. Simpson, L. L. (1986). Molecular pharmacology of botulinum toxin and tetanus toxin. Annu. Rev. Pharmacol. Toxicol. 26, 427-453.
43. Tomsak, R. L., Remler, B. F., Averbach-Heller, L., Chandran, M. and Leigh, R. J. (1995). Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin. Am. J. Ophthalmol. 119, 489-496.